baber/WOPTO huggingface dataset:
Patent NZ-543758-A (NZ)
Title: Acyl urea, carbamate, thiocarbamate and related compounds for treatment of inflammation, diabetes and related disorders
Inventor: NEOGI PARTHA
IPC: C07C235/34
Filed: 2004-05-07
Abstract: Disclosed are compounds of formula (VIII), wherein the substituents are as defined in the specification. N,N-Dimethyl-2-{4-[4-(3-oxo-3-ureidopropyl)-phenoxy]-phenyl}-3-(pyridin-3-yl)-acrylamide is one such example of the compound of formula (VIII). The compounds are useful in the treatment of diabetes, inflammatory and immunological disease, hyperlipidemia and coronary heart disease.
Patent NZ-547140-A (NZ)
Title: Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
Inventor: HILL RONALD STEWART
IPC: A61K35/32
Filed: 2004-10-22
Abstract: Disclosed is the use of a bioactive hydrogel matrix comprising a polypeptide and a long chain carbohydrate in the manufacture of a composition for regenerating connective tissue, wherein the composition is formulated for administration to a site in need of connective tissue regeneration, wherein the bioactive hydrogel matrix further comprises one or more components selected from the group consisting of polar amino acids, divalent cation chelators, and combinations thereof, and wherein the bioactive hydrogel matrix is in dehydrated form.
Patent NZ-547787-A (NZ)
Title: Composition for thermal insulating layer
Inventor: WACHTELL PETER
IPC: C09D7/61
Filed: 2004-11-12
Abstract: Disclosed is a curable coating composition for forming a thermal insulating layer, wherein the composition comprises: (a) porous particles of a material obtained by drying a wet sol-gel, the particles having a porosity of at least 80% and a particle size in the range from 5 ìm to 4.0 mm; and (b) a film forming resin system comprising a film forming polymer, wherein the particles (a) are dispersed in the resin system (b), and the resin system (b) contains at least one stabilizer having an average molecular weight in the range from 1,000 to 4,000, said stabilizer being at least one member selected from the group consisting of ethylene oxide-propylene oxide block copolymers, poly C2-C3 alkoxylated C12-C18 saturated or unsaturated fatty alcohols, poly C2-C3 alkoxylated hydrogenated or partially hydrogenated castor oils, poly C2-C3 alkoxylated hydrogenated or partially hydrogenated soybean oils, polydimethyl siloxane C2-C3 alkoxylates, and sorbitan esters of C12-C18 saturated or unsaturated fatty acids, the amount of the particles (a) is in the range from 2 to 6% by weight, based on the weight of the composition, and the amount of the stabilizer is in the range from 50% to 90% by weight, based on the weight of the porous particles.
Patent NZ-549876-A (NZ)
Title: Appliance audio notification device
Inventor: HAYES BOBBY
IPC: G10H1/00
Filed: 2005-03-09
Abstract: An audio tone-generating device for use in a consumer appliance, such as a washing machine, is disclosed. The device generates musical tones. The device uses two outputs of a software-executing processor utilizing stored tone data associated with status events of the appliance to drive a tone circuit for outputting a melody using the tones to notify the user of the existence of one of the status events.
Patent NZ-550472-A (NZ)
Title: Dispensing apparatus
Inventor: MENDES TOMAS ANTONIO DOS SANTOS
Filed: 2006-10-11
Abstract: A dispensing apparatus for gravity feeding of a dispensable product includes containing means and dispensing means. The containing means is adapted to contain the dispensable product and is operatively connected to the dispensing means whereby the dispensing means includes a chute means. Rotation of the chute means can cause the dispensable product to be able to be dispensed.
Patent NZ-552471-A (NZ)
Title: Patient lifting device that adjusts to the individual patient and supports them under the arms and legs
Inventor: WALKER SIMON CHRISTOPHER DORNTON
IPC: A61G7/10
Filed: 2004-06-12
Abstract: A patient lifting device is disclosed. The device has two side limbs (2) each connected at an upper end (2a) to a suspension mounting (3). The suspension mounting (3) can be used to hang the device from a lifting hook of a hoist. Each side limb (2) is provided with a support bar (48) at a lower end (2b) which mounts patient support elements. The patient support elements are a pair of side pads (47) for engaging beneath the armpits of a patient and against opposite sides of the patient's ribcage, and a patient upper leg or posterior support means (44). The two support bars (48) are connected together by a link bar assembly (43, 45) from which the patient upper leg or posterior support means (44) depends. Each support bar (2) is also pivotally mounted on its respective side limb about a pivotal axis (25). This pivot axis (25) defines a balance axis about which the moments imparted by the weight of the patient's upper body through the side pads (47) and by the weight of the patient's lower body through the upper leg or posterior support means (44) can react against one another in an equal and opposite fashion.
Patent NZ-554307-A (NZ)
Title: Process for purifying a protein of interest from a heterogeneous tissue culture fluid mixture
Inventor: WU PENG
IPC: A61K38/00
Filed: 2005-09-30
Abstract: A process and apparatus for purifying a protein of interest from a heterogeneous tissue culture fluid mixture is disclosed. The apparatus of the invention generally comprises a continuous perfusion fermentation system, a continuous particle removal system integrated with the perfusion fermentation system; and a continuous purification system integrated with the particle removal system, which is maintained under sterile conditions. The process comprises at least the following steps: (a) Production of a heterogeneous tissue culture fluid mixture containing protein of interest using a continuous perfusion fermentation process. (b) Transfer of the tissue culture fluid mixture to a continuous particle removal process integrated with the continuous perfusion fermentation process. (c) Removal of particulate contaminants from the tissue culture fluid in the continuous particle removal process to produce a clarified tissue culture fluid containing the protein of interest. (d) Transfer of the clarified tissue culture fluid either to a continuous ultrafiltration process or to a surge vessel integrated with the continuous particle removal process. (e) Purification of the protein of interest from the clarified tissue culture fluid wherein the specific flow rate of the mixture through at least the continuous perfusion fermentation process and continuous particle removal process is maintained substantially constant.
Patent NZ-562120-A (NZ)
Title: Composition comprising donepezil and memantine as antidementia agents
Inventor: KIMURA SUSUMU
IPC: A61K31/445
Filed: 2006-04-28
Abstract: Disclosed is a composition comprising donepezil or a pharmaceutically acceptable salt thereof and memantine or a pharmaceutically acceptable salt thereof, wherein the composition comprises a sustained release portion comprising a non-pH-dependent polymeric substance or a pH-dependent polymeric substance.
Patent NZ-565561-A (NZ)
Title: Formulation of radioprotective alpha, beta unsaturated aryl sulfones
Inventor: MANIAR MANOJ
IPC: A61K31/10
Filed: 2006-07-28
Abstract: Disclosed is a pharmaceutical composition for use in reducing toxic effects of ionizing radiation in a subject comprising between about 20mg/ml to about 60mg/ml of at least one radioprotective alpha, beta unsaturated aryl sulfone and at least one component selected from the group consisting of a) at least one chemically modified cyclodextrin selected from the group consisting of 2-hydroxypropyl-betacyclodextrin, 2-hydroxypropyl-gamma-cyclodextrin, and hydroxyethyl-betacyclodextrin in an amount between about 20 percent and about 60 percent w/v, b) a water soluble polymer selected from the group consisting of povidone in an amount between about 0.5 percent and about 20 percent w/v and PEG in an amount between about 25 percent and about 90 percent and c) N,N-dimethylacetamide (DMA) in an amount between about 10 percent and about 50 percent w/v, wherein the composition has a pH within the range of about 7.5 to about 9.2.
Patent NZ-569895-A (NZ)
Title: Back supporting device for use on a highchair held in place by a safety bow
Inventor: OPSVIK PETER
IPC: A47D15/00
Filed: 2007-02-23
Abstract: A back support device (60) for use in a children's chair (1) is disclosed. It is used in conjunction with and existing detachable safety bow (100) which holds it in place. The children's chair comprises at least one backrest (3, 4), two side pieces (5), one seat plate (2) and the safety bow (100) with ends (101). The backrest (3, 4) or the side pieces (5) have at least one opening or groove each to accept the back support device (60) and bow (100). The back support device (60) has left and right arms to at least partly inlay into the opening(s) or groove(s) in the backrest (3, 4) or the side pieces (5). The ends of the arms of the back support device (60) are locked in the opening(s) or groove(s) by the safety bow (100). The back support device (60) may have a top part (61) increasing the effective height of the backrest (3, 4).
Patent NZ-569905-A (NZ)
Title: Amino acid mixture-containing agent capable of raising body temperature for food or drink use and medical use
Inventor: ABE TAKASHI
IPC: A61P3/02
Filed: 2002-06-06
Abstract: Disclosed is the use of an agent which comprises, as an active ingredient, an amino acids mixture, wherein the ratio of the amino acids is from 2 to 15 moles threonine, from 4 to 30 moles of proline, from 7 to 20 moles of glycine, from 4 to 8 moles of valine, from 3 to 9 moles of isoleucine, from 2 to 12 moles of leucine, from 1 to 9 moles of tyrosine, from 0.5 to 5 moles of phenylalanine, from 5 to 11 moles of lysine, from 0.1 to 5 moles of aspartic acid, from 0.1 to 5 moles of serine, from 0.1 to 4 moles of glutamic acid, from 0.1 to 12 moles of alanine, from 0.1 to 5 moles of methionine, from 0.1 to 5 moles of histidine and from 0.1 to 5 moles of arginine, in the manufacture of a composition for the treatment of cold constitution.
Patent NZ-577075-A (NZ)
Title: Modulation of prostaglandin/cyclooxygenase metabolic pathways
Inventor: WULFERT ERNST
IPC: A61K31/437
Filed: 2007-11-29
Abstract: Disclosed is the use of 7á- or 7â-hydroxyepiandrosterone or an ester thereof, for the manufacture of a medicament for the treatment or prophylaxis of an inflammatory condition selected from the group of: peripheral arterial diseases and their sequelae such as critical limb ischaemia; coronary artery disease and its sequelae; atherosclerotic renal artery stenosis; diabetes mellitus and its sequelae including type 2 diabetes and its sequelae; inflammatory skin conditions; multiple sclerosis; inflammatory bowel disease; rheumatoid arthritis and primary and secondary osteoarthritis and their sequelae; inflammatory diseases characterised by degeneration of articular cartilage acromegaly; and inflammation or inflammatory diseases of peripheral organs selected from the liver or kidney; and inflammatory airway diseases.
Patent NZ-579777-A (NZ)
Title: Dietary supplement, and methods of use
Inventor: GAHLER ROLAND J
IPC: A23L21/10
Filed: 2006-04-10
Abstract: Provided is a dietary fiber composition comprising from about 48% to about 90% (w/w) glucomannan, from about 5% to about 20% (w/w) xanthan gum, and from about 5% to about 30% (w/w) alginate, wherein the composition is not granulated. The composition is useful to suppress appetite and to promote weight loss. (62) Divided Out of 561819
Patent NZ-584659-A (NZ)
Title: Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
Inventor: CHANG YUNG-FU
IPC: A61K39/04
Filed: 2008-10-09
Abstract: Disclosed is a composition comprising a recombinant protein comprising from N-terminus to C terminus: i) a C-terminal fragment of Map3527 protein; ii) a Map1519 protein sequence; and iii) an N-terminal fragment of Map3527 protein. Also disclosed is a method for stimulating an immune response to Mycobacterium avium subspecies paratuberculosis (MAP) in a non-human mammal and the use if the composition in a medicament for treating a Mycobacterium avium subspecies paratuberculosis (MAP) infection. .
Patent NZ-590109-A (NZ)
Title: Dishwasher machine comprising a sorption drying device in a pot shaped container with a sealed cover lid
Inventor: JERG HELMUT
IPC: A47L15/48
Filed: 2009-07-28
Abstract: Disclosed is a dishwasher machine comprising at least one washing compartment and at least one sorption drying system for drying items that have been washed. The sorption drying system comprises at least one sorption compartment comprises a pot-type housing part with a heater element which is closed by a cover part, that contains the reversibly dehydratable sorption material held between two sieve or grid elements, the sorption compartment being connected to the washing compartment by means of at least one air-guiding channel for the generation of an air flow that guides air out of the washing compartment into the sorption compartment by means of the air guiding channel can flow through its sorption material substantially in or against the direction of gravity.
Patent NZ-591972-A (NZ)
Title: Production of modified fatty acids in plants
Inventor: FABIJANSKI STEVEN
IPC: A01H5/00
Filed: 2009-09-30
Abstract: The present invention relates to transgenic plants comprising a plurality of nucleic acids heterologous to said plant, each of said nucleic acid comprising a coding sequence operably linked to one or more regulatory elements for directing expression of said coding sequence in said plant, said nucleic acid being stably integrated at or adjacent to rDNA sequences, or a seed, organ, tissue, part or cell thereof, or a descendant of said plant, seed, organ, tissue, part or cell; methods of producing the transgenic plants; and methods of producing oil using the transgenic plants.
Patent NZ-593954-A (NZ)
Title: Saccharide conjugate vaccines comprising CD4+ T cell epitopes selected from tetanus toxin, Plasmodium falciparum circumsporozoite protein (PfCSP), Hepatitis B virus nucleocapsid (HBVnc), Influenza virus haemagglutinin (HA), Hepatitis B virus surface antigen (HBsAg) and Influenza virus matrix protein (MT) and a saccharide antigen
Inventor: DEL GIUDICE GIUSEPPE
IPC: A61K39/09
Filed: 2005-12-23
Abstract: 593954 Disclosed is a composition comprising a combination of two or more monovalent conjugates, wherein each of said two or more monovalent conjugates comprises a carrier protein comprising CD4 T cell epitopes from two or more pathogen conjugated to a saccharide antigen, wherein: The epitopes are selected from tetanus toxin (TT), Plasmodium falciparum circumsporozoite protein (PfCSP), Hepatitis B virus nucleocapsid (HBVnc), Influenza virus haemagglutinin (HA), Hepatitis B virus surface antigen (HBsAg) and Influenza virus matrix protein (MT); and At least one of the conjugates comprises a saccharide antigen other than Haemophilus influenza type b (Hib).
Patent NZ-594414-A (NZ)
Title: Fused amino pyridines for the treatment of brain tumors
Inventor: QIAN CHANGGENG
IPC: A01N43/50
Filed: 2010-01-15
Abstract: ABSTRACT - 594414 The disclosure relates to the use of compounds with fused amino pyridine core represented by the structural formulae shown herein for the treatment of malignancies associated with brain and lung. The oral administration of compounds of the instant application results in effective brain penetration and provides for non-intrusive treatment of brain and lung tumors.
Patent NZ-595568-A (NZ)
Title: Chocolate composition
Inventor: WALES ANDREW
IPC: A23G1/00
Filed: 2010-04-19
Abstract: Disclosed is a chocolate composition comprising 50-65 percent sweetener, 25-30 percent cocoa butter substitute (CBS) and/or cocoa equivalent (CBE), 4-10 percent non-fat cocoa solids, milk solids and from 0-2 percent cocoa butter, wherein at least 80 percent of the milk solids are constituted by whey.
Patent NZ-596013-A (NZ)
Title: Anti-mesothelin immunoconjugates and uses therefor
Inventor: HEISLER IRING
IPC: A61K47/48
Filed: 2010-04-16
Abstract: 596013 Disclosed is an immunoconjugate comprising a cytotoxic agent and a human or humanized antibody or functional fragment thereof comprising an antigen binding site that is specific for Mesothelin, wherein said antibody or functional fragment thereof exhibits invariant binding of Mesothelin and, wherein the antibody binding site includes a CDR 1, CDR 2 and CDR 3 wherein: a) said CDR 1 is selected from SEQ ID NO: 3 and 12 (GYSFTSYWIG, WMGIIDPGDSRTRYSPSFQG), b) said CDR 2 is selected from SEQ ID NO: 6 and 15 (GQLYGGTYMDG, TGTSSDIGGYNSVS), c) said CDR 3 is selected from SEQ ID NO: 9 and 19 (LMIYGVNNRPS, SSYDIESATP), and the cytotoxic agent consists of maytansinoid or a derivative thereof.
Patent NZ-603632-A (NZ)
Title: Cutter, packaging apparatus and method of cutting a film
Inventor: GRANILI ANDREA
IPC: B26D1/08
Filed: 2012-11-15
Abstract: A packaging apparatus includes a film cutter blade 20 that is formed into a closed shape and which has a plurality of first teeth A1 and a plurality of second teeth A2. The first teeth are longer than the second teeth so that in use the first teeth contact a surface of the film 15 to be cut before the second teeth do. In practice the blade is forced downwardly onto the film forming a lid of a film sealed package so that the film is cut neatly around the periphery of the package with a single downward stroke of the blade.
Patent NZ-609011-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P7/10
Filed: 2010-02-11
Abstract: 609011 Disclosed is a method of producing a treated biomass comprising: determining the lignin content of a biomass feedstock, irradiating the biomass feedstock with a dosage of ionizing radiation, and mechanically treating the biomass feedstock, wherein irradiating is done utilizing ionizing radiation and the dosage of ionizing radiation is set based on an empirically determined relationship between lignin content of the feedstock, recalcitrance of the feedstock, reduced recalcitrance of the treated biomass and dosage of said the ionizing radiation, thereby providing a treated biomass having reduced recalcitrance relative to the recalcitrance of the biomass feedstock.
Patent NZ-610547-A (NZ)
Title: Novel monensin derivatives for the treatment and prevention of protozoal infections
Inventor: DELAVEAU JEAN
IPC: C07D519/00
Filed: 2011-11-16
Abstract: Patent No. 610547 Disclosed are compounds I and II, such as 1-benzylamidomonensine and monensin lactone, which are useful to treat coccidosis and babesiosis.
Patent NZ-613875-A (NZ)
Title: Apparatus and method for the dredging of sediments from the seabed
Inventor: BENEDETTI DAVIDE
IPC: F04D29/70
Filed: 2012-01-23
Abstract: A dredging apparatus (1) is described for removing sediments from a bed (F) of an expanse of water (see S, figure 1). The apparatus comprises a suction apparatus (5). The suction apparatus (5) includes a submersible pump (18) and a suction head (9). The submersible pump includes a housing body (17), provided with an inlet mouth (19) and a discharge opening (20), and an impeller (21) rotatably supported in the body between the inlet mouth and the discharge opening, and rotatably driven by a respective driving device (see 22, figure 9). The suction head is associated with the inlet mouth of the housing body of the pump and is provided at the bottom with a suction opening (23). The suction opening of the head has a cross-sectional area dimensioned to achieve, in the working range of the pump, a suction speed capable of removing sediment. The dredging apparatus further comprises a separating device (8) and a recirculation system (10). The separating device (8) separates a slurry of water and sediments received from the suction apparatus (5) into a liquid phase and a solid phase. The liquid phase is then recirculated via the recirculation system (10) to an inner hollow space (34) in the suction head, which annularly surrounds the suction opening (23). The inner hollow space directs the recirculated liquid phase toward the suction opening in inside the suction head. The recirculation system (10) defines a closed hydraulic circuit of the fluid recirculating therein. A dredging method, utilising such an apparatus, is also disclosed.
Patent NZ-614387-A (NZ)
Title: An electrically heated smoking system
Inventor: CORDEY JEAN-PIERRE
IPC: A24F40/65
Filed: 2009-04-15
Abstract: Disclosed is an Internet-enabled host (109) for uploading data to and downloading data from an electrically heated smoking system (103) which has an electrical hardware programmable by software. The host (109) includes an interface (107) for establishing a communications link with the electrically heated smoking system (103) for uploading data to and downloading data from the Internet-enabled host (109). A processor and memory are configured to implement instructions stored in the memory. The instructions involve downloading and analysing data from the electrically heated smoking system (103), requesting data from the Internet, in dependence on the analysis, and uploading data from the Internet, or from the memory in dependence on the data received from the Internet, to the electrically heated smoking system (103). The uploaded data includes software for programming the electrical hardware of the electrically heated smoking system (103).
Patent NZ-619365-A (NZ)
Title: Closure framing system
Inventor: DAVID FRANK BURGGRAAF
IPC: E06B7/14
Filed: 2012-12-24
Abstract: A head flashing element 1700 for facilitating the framing of an opening in a building having an outer cladding layer includes an eave formation 1700 with a portion extending laterally outwardly of the outer cladding layer of the building and along an outer surface of the outer cladding layer. An adjustable return 1604 is carried by the extending portion and is disposed to partially overlap the extending portion and in use to adjustably extend from the extending portion to and be positioned against the outer surface of the cladding. The adjustable return may include a flap 1605 that lays against the surface of the outer cladding.
Patent NZ-705075-A (NZ)
Title: Method and system for selectively biased linear discriminant analysis in automatic speech recognition systems
Inventor: GANAPATHIRAJU ARAVIND
IPC: G10L15/14
Filed: 2013-08-23
Abstract: A system and method are presented for selectively biased linear discriminant analysis in automatic speech recognition systems. Linear Discriminant Analysis (LDA) may be used to improve the discrimination between the hidden Markov model (HMM) tied-states in the acoustic feature space. The between-class and within-class covariance matrices may be biased based on the observed recognition errors of the tied-states, such as shared HMM states of the context dependent tri-phone acoustic model. The recognition errors may be obtained from a trained maximum-likelihood acoustic model utilizing the tied-states which may then be used as classes in the analysis.
Patent NZ-708457-A (NZ)
Title: Compositions and methods of aloe polysaccharides
Inventor: DANHOF IVAN E
IPC: C08B37/04
Filed: 2011-01-06
Abstract: Disclosed is a composition consisting of an injectable formulation of a polymannan extract comprising: a specified quantity of polymannan extract dissolved in deionized water wherein the polymannan extract comprises aloe polysaccharides that have a molecular weight ranging from 11,500 Daltons to over 10,000,000 Daltons and at least 2.4% of the aloe polysaccharides have a molecular weight of 2,000,000 Daltons or greater; and one or more pharmaceutical preservatives. Also disclosed is its use in the preparation of a medicament for the treatment of one or more cancers.